Belite Bio, Inc.
BLTE.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Belite Bio, Inc. is a biopharmaceutical company focused on developing novel therapeutics for inherited retinal diseases with unmet medical needs like Stargardt disease. They are involved in the research, development, and commercialization of treatments for retinal degenerative diseases and metabolic...Show More
Better Health for All
10
Belite Bio's core business is developing Tinlarebant, a drug intended to slow the progression of Stargardt disease and Geographic Atrophy, for which there are currently no FDA-approved oral treatments.
1
In a Phase 3 trial, Tinlarebant showed a roughly 36% reduction in the growth rate of retinal lesions over two years compared to a placebo, and stabilization of visual acuity loss in some patients.
2
The company has no products with negative health impacts. Tinlarebant was consistently reported as well-tolerated in trials, with only four patients out of 104 stopping treatment due to adverse events, and most common side effects were mild and resolved.
3
The clinical trials are described as randomized, double-masked, placebo-controlled, and multi-center, and received positive recommendations from trial monitors to continue without modifications.
4
Fair Money & Economic Opportunity
0
Belite Bio, Inc. is a biopharmaceutical company focused on developing therapeutics for retinal diseases.
1
The provided articles consistently describe the company's activities as drug development, clinical trials, and regulatory designations for medical treatments. The company does not operate as a financial institution, nor does it offer lending, deposit services, consumer credit products, financial education, or any other financial services.
2
Therefore, all KPIs under the 'Fair Money & Economic Opportunity' value are not applicable to its business model.
Fair Pay & Worker Respect
0
No evidence available to assess Belite Bio, Inc on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
Belite Bio, Inc. is a biopharmaceutical company focused on clinical-stage drug development.
1
This operational focus means the company does not procure or trade physical commodities, making fair-trade certification and material risk indices not applicable to its operations. No specific, quantitative evidence was found in the provided articles for the remaining KPIs related to fair trade and ethical sourcing, leading to their omission.
2
Honest & Fair Business
30
The company has a Whistleblower Policy that mandates employees report violations, with failure to report being a violation itself.
1
Reports can be made confidentially and anonymously via a 24/7 third-party operated website and hotline, and employees reporting in good faith are protected from retaliation.
2
Belite Bio also maintains an Anti-Corruption Policy that prohibits giving anything of value to foreign officials, in compliance with the U.S. Foreign Corrupt Practices Act (FCPA).
3
This policy allows for nominal facilitating payments in limited circumstances, but these require advance approval from a supervisor or the board of directors.
4
Kind to Animals
0
No specific, concrete evidence was found in the provided articles regarding Belite Bio, Inc.'s performance or policies related to animal welfare, animal testing, cruelty-free certifications, ethical sourcing, or conservation efforts. The articles primarily focus on the company's financial performance, clinical trial progress for human diseases, and general industry news, without providing data points relevant to the 'Kind to Animals' KPIs for Belite Bio, Inc.
1
No War, No Weapons
0
No specific, concrete data points were found in the provided articles to assess Belite Bio, Inc. against the 'No War, No Weapons' ethical value. The articles explicitly state that no sustainability data or information relevant to arms, defense, or dual-use technologies is available for the company.
1
Planet-Friendly Business
0
The provided articles focus on Belite Bio's clinical trial progress and financial results.
1
None of the articles contain specific, quantitative, or qualitative data points related to any of the 'Planet-Friendly Business' KPIs, such as greenhouse gas emissions, renewable energy use, water consumption, waste diversion, or environmental compliance.
2
Therefore, no KPIs can be scored based on the evidence provided.
Respect for Cultures & Communities
0
No specific, concrete evidence was found in the provided articles regarding Belite Bio, Inc.'s performance on any of the KPIs related to 'Respect for Cultures & Communities'. The articles primarily focus on the company's clinical trial progress and regulatory designations for its drug candidate, Tinlarebant, and general industry discussions on clinical trial diversity, without providing data on community engagement, cultural impact, or social license for Belite Bio.
Safe & Smart Tech
0
No evidence available to assess Belite Bio, Inc on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific data relevant to waste diversion, sustainable products, or other metrics related to zero waste and sustainability were found in the provided articles.
1
The articles primarily focused on ESG ranking, clinical trials, and financial results, without quantitative data, regulatory actions, certifications, or comparisons related to the ethical value.
2